Skip to content
matthewsimpson3's profile image - click for profile

Matthew Simpson's Fundraiser:

Ayahuasca and Our Nation's Warriors - Treating veteran's with PTSD

Matthew's Photo
Matthew Simpson


Veteran's for Entheogenic Therapy(VET) is currently raising funds to treat our nation's warriors with the plant medicine Ayahuasca. Over the past 3 years, with minimal funding VET has treated over 150 treatment resistant veteran's with ayahuasca and has had overwhelming success combating the PTSD from war trauma. Currently, VET has 500+ qualified veterans on the waiting list in dire need of this treatment. As we all know, anywhere from 22-50 veterans kill themselves each day at the hand of suicide and the VA (Veteran's Administration) has no answer. Collectively, we have no answer. You can help! Every dollar donated goes directly to travel and retreat expenses for our oh so deserving nation's warriors that have put everything on the line for our freedoms and personal liberties, for our comforts and way of life. This is real. In addition to helping our warrior's get the treatment you will be funding observational research in hopes of starting clinical trials with the FDA in the years to come. Give Back to Those Who Gave All Who is Veterans for Entheogenic Therapy (VET)? We are a group of veterans seeking financial support from you to provide awareness, education, safety, and research around alternative options including ayahuasca for veterans suffering from a complex issue that is facing the nation today: Post-traumatic Stress Disorder or PTSD. Ryan LeCompte, the founder of VET is a former United States Marine infantryman (MOS 0311) who served on active-duty from 2007-2011. He is also a graduate student completing a Masters Degree in Transpersonal Counseling Psychology at Naropa University in Boulder, CO More info here:



Want to help Fundraise or Volunteer for this amazing Fundraiser? Join the Team

Donor Comments

Be the first to Donate to Matthew and Ayahuasca and Our Nation's Warriors - Treating veteran's with PTSD.